Liver injury associated with anti-tumour necrosis factor therapy in paediatric irritable bowel disease patients

被引：0
|
作者：
Ricciuto, A. [1 ]
Kamath, B. M. [1 ]
Walters, T. [1 ]
Church, P. [1 ]
Ling, S. C. [1 ]
Frost, K. [1 ]
Griffiths, A. [1 ]
机构：
[1] Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P435
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [11] Role of Anti-Tumour Necrosis Factor Alpha Treatment in Patients With Autoimmune Liver Disease
    Vadamalayan, Babu
    Banur, Dinesh
    Samyn, Marianne
    Mieli-Vergani, Giorgina
    Hadzic, Nedim
    GASTROENTEROLOGY, 2013, 144 (05) : S447 - S447
  • [12] Oral manifestations in inflammatory bowel disease patients under anti-tumour necrosis factor treatment
    Barreiro-de Acosta, M.
    Rio, P.
    Ferreiro, R.
    Bouza, M. J.
    Pombo, M. D. C.
    Lorenzo, A.
    Gallas, M.
    Dominguez-Munoz, J. E.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S202 - S203
  • [13] Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's disease
    Mak, Joyce Wing Yan
    Tang, Whitney
    Yip, Terry Cheuk Fung
    Ran, Zhi Hua
    Wei, Shu Chen
    Ahuja, Vineet
    Kumar, Sudheer
    Leung, Wai Keung
    Hilmi, Ida
    Limsrivilai, Julajak
    Aniwan, Satimai
    Lam, Belsy C. Y.
    Chan, Kam Hon
    Ng, Ka Man
    Leung, Chi Man
    Li, Michael K. K.
    Lo, Fu Hang
    Sze, Alex Shun Fung
    Tsang, Steven Woon Choy
    Hui, Aric J.
    Hartono, Juanda Leo
    Ng, Siew C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (11-12) : 1195 - 1203
  • [14] Evaluating the impact of anti-tumour necrosis factor and small molecules therapy on depression and anxiety for inflammatory bowel disease patients
    Kashani, Irwin
    Mountifield, Reme
    Barnes, Alex
    Mangoni, Arduino
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 250 - 250
  • [15] Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in Australia
    Connell, W.
    Andrews, J. M.
    Brown, S.
    Sparrow, M.
    INTERNAL MEDICINE JOURNAL, 2010, 40 (02) : 139 - 149
  • [16] A SINGLE-CELL THERAPEUTIC ATLAS OF ANTI-TUMOUR NECROSIS FACTOR THERAPY IN INFLAMMATORY BOWEL DISEASE
    Thomas, Tom
    Rich-Griffin, Charlotte
    Pohin, Mathilde
    Friedrich, Matthias
    Kulicke, Ruth
    Bielecki, Piotr
    Spies, Noah
    Travis, Simon P.
    Uhlig, Holm
    Dendrou, Calliope
    Buckley, Christopher D.
    GASTROENTEROLOGY, 2023, 164 (06) : S123 - S123
  • [17] Anti-tumour necrosis factor (TNF)-α therapy (etanercept)
    Maya Buch
    Arthritis Research & Therapy, 4 (1)
  • [18] Anti-tumour necrosis factor therapy in the West Midlands
    Bartram, D
    Sheeran, T
    Price, T
    Mulherin, D
    RHEUMATOLOGY, 2004, 43 (03) : 400 - 400
  • [19] Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents
    Karmiris, Konstantinos
    Bossuyt, Peter
    Sorrentino, Dario
    Moreels, Tom
    Scarcelli, Antonella
    Legido, Jesus
    Dotan, Iris
    Naismith, Graham D.
    Jussila, Airi
    Preiss, Jan C.
    Kruis, Wolfgang
    Li, Andy C. Y.
    Bouguen, Guillaume
    Yanai, Henit
    Steinwurz, Flavio
    Katsanos, Konstantinos H.
    Subramaniam, Kavitha
    Tarabar, Dino
    Zaganas, Ioannis V.
    Ben-Horin, Shomron
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (05): : 382 - 389
  • [20] Anti-tumour necrosis factor therapy in seronegative spondyloarthritis
    Swales, C
    Bowness, P
    CLINICAL MEDICINE, 2005, 5 (03) : 219 - 222
12345